Ding et al. showed that a history of diabetes in CRC patients was associated with tissue expression of the main components of the IGF axis, and that higher tumor (T) stage and lymph node metastases were respectively independent factors of IGF-1 and IGF-1R expression in these patients. This evidence concerns the gene IGF1 and diabetes mellitus.